Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
-30.70%
20%
—
—
60%
—
5 Years
Score—
Net Growth-30.70%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev Trend60%
Revenue Consistency—
Lyra Therapeutics Inc fundamental performance
Across Lyra Therapeutics Inc's full reported history, from 2020 to 2025, revenue grew from $ 0.00 to $ 398K and net income went from -$ 22M to -$ 28M. Revenue increased in 60% of the years measured; net income in 20%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.25 | — |
1 Year2025-08-12 | $ 6.75 | -96.30% |
5 Years2021-08-12 | $ 369.00 | -99.93% |
All Time2020-05-01 | $ 928.00 | -99.97% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-05-01 |
|---|---|---|---|---|
| Price | $ 0.25 | $ 6.75 | $ 369.00 | $ 928.00 |
| Return | — | -96.30% | -99.93% | -99.97% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 398K | -$ 28M | $ 15M |
| 2024 | $ 1M | -$ 93M | $ 40M |
| 2023 | $ 1M | -$ 62M | $ 102M |
| 2022 | $ 1M | -$ 55M | $ 97M |
| 2021 | $ 285K | -$ 42M | $ 45M |
| IPO2020 | $ 0.00 | -$ 22M | $ 74M |
Explore beyond LYRA
You're looking at Lyra Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
